Cited by 63Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS

Zheng, Sai-Hua, Li, Xue-Lian·2016·Gynecological Endocrinology

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disease which often accompany with abnormal fat distribution. Visceral adiposity has association with abnormal lipid metabolic, pro-inflammatory activity, insulin resistance (IR) and hyperandrogenism. Increased visceral adiposity raises the risk of metabolic syndrome, type 2 diabetes and cardiovascular (CV) events, and aggravates ovulatory dysfunction and hyperandrogenism in PCOS women. Visceral adiposity index (VAI), a simple surrogate maker of visceral adipose dysfunction and visceral adiposity, is a predictor of IR, and link hyperinsulinemia, hyperandrogenism and anovulation. This review aims to discuss the visceral adiposity situation in PCOS women, and suggests that VAI may be a useful predictor of clinical severity and therapeutic outcome of PCOS.

Integrity signals

Registry

Crossref · 10.3109/09513590.2015.1111327

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

Authors
Zheng, S.-H., & Li, X.-L.
Affiliations
Shanghai Medical College of Fudan University (CN)
Corresponding author
Li, Xue-Lian
Venue
Gynecological Endocrinology
Published
2015-11-20
Volume
32
Issue
3
Pages
177-183
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W1823276895
Cited by
63
References
10
Citations by year
2026: 1 · 2025: 9 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 5
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
polycystic ovary syndrome, visceral adiposity index, visceral fat, insulin resistance, hyperandrogenism, anovulation, metabolic syndrome, cardiovascular risk, treatment outcome prediction, clinical severity
MeSH terms
Cardiovascular Diseases, Female, Humans, Inflammation, Insulin Resistance, Menstruation Disturbances, Polycystic Ovary Syndrome, Severity of Illness Index, Hyperandrogenism, Intra-Abdominal Fat, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review